Array Technologies, Inc. (ARRY) by event type
ARRY moves most on rating reiterations — a median of -0.43% at 30 minutes across 92 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ARRY overview →
How ARRY reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 626 of 2,717 | 16 | +0.29% | 56% | +1.11% |
| Analyst downgrades 1,694 of 2,603 | 26 | -0.10% | 42% | -0.20% |
| Coverage initiations 1,832 of 2,283 | 21 | -0.39% | 33% | -1.86% |
| Rating reiterations 3,269 of 3,522 | 92 | -0.43% | 36% | -0.70% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how ARRY usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · ARRY overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | 250 | 0.00% | 46% |
| argenx SE - American Depositary Shares (ARGX) | 249 | -0.02% | 48% |
| Cytosorbents Corporation (CTSO) | 249 | 0.00% | 49% |
| IRIDEX Corporation (IRIX) | 248 | +0.11% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.